64º
    • News
    • Watch Live
    • Michigan COVID
    • Get Caught Up
    • Elections
    • Help Me Hank
    • Health
    • Local News
    • National
    • World
    • Community
    • Investigations
    • Entertainment
    • Environment
    • Politics
    • Flashpoint
    • Trust Index
    • Solutionaries
    • Meet The Team
    • Sports
    • Lions
    • Lions Stats
    • Tigers
    • Tigers Stats
    • Red Wings
    • Red Wings Stats
    • Pistons
    • Pistons Stats
    • Wolverines
    • Spartans
    • 4Frenzy
    • Bob Krause Golf
    • Features
    • Watch Local 4+
    • Parade
    • Vote 4 The Best
    • Click On Deals
    • Jobs 4 You
    • 4YI
    • All 4 Pets
    • Tech Time
    • Travel
    • Something Good
    • Mental Health Matters
    • StyleWise
    • Money Minute
    • Tasty Tuesday
    • Fitness Friday
    • Brag Book
    • Sunshine Awards
    • In The D
    • Food
    • TV Listings
    • MeTV Detroit
    • Contests
    • Live In The D
    • Dine In The D
    • Click On Deals
    • What's The Buzz
    • Uniquely Detroit
    • Events Live Guide
    • Ann Arbor
    • Headlines
    • Topics
    • Sports
    • Events
    • Ann Arbor Weather
    • Get Involved
    • Weather
    • Weather Center
    • Weather News
    • Alerts
    • StormPins
    • School Closings
    • Forecasting Change
    • 4ZONE - Metro
    • 4ZONE - North
    • 4ZONE - South
    • 4ZONE - West
    • Traffic
    • Road Construction Updates
    • Live Traffic Map
    • Newsletters
    • Contact Us
  • News
  • Sports
  • Features
  • Live In The D
  • Ann Arbor
  • Weather
  • Traffic
  • Newsletters
  • Contact Us
ClickOnDetroit.com
  • News
  • Sports
  • Features
  • Live In The D
  • Ann Arbor
  • Weather
  • Traffic
  • Newsletters
  • Contact Us
Ad

MARTIN SHKRELI


'Pharma Bro' Martin Shkreli has been released from prison

Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was sentenced to seven years in prison in for securities fraud in 2018.

npr.org

'Pharma Bro' Shkreli freed from prison for halfway house

Convicted pharmaceutical executive Martin Shkreli has been freed from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company.

'Pharma bro' Martin Shkreli released from federal prison and into New York halfway house

Martin Shkreli will his securities fraud sentence in September. He gained infamy for raising the price of a drug by more than 4,000%.

cnbc.com

Martin Shkreli, Wall Street’s ‘Pharma Bro,’ is out of prison early

Shkreli has been released from an Allenwood, Pa. prison early and is being taken by a friend to a halfway house, according to a statement from his lawyer.

washingtonpost.com

Judge rejects bid by 'Pharma bro' Martin Shkreli to delay paying more than $24.6 million in FTC lawsuit related to medication

Martin Shkreli lost the civil case involving the drug Daraprim while serving a criminal sentence for unrelated securities fraud.

cnbc.com

Court fight looms as questions swirl over Trump's finances

Questions about Donald Trump’s business practices are piling up.

Companies founded by Pharma Bro Martin Shkreli will pay up to $28M in class-action settlement over Daraprim price hike

Martin Shkreli raised the price of the prescription drug Daraprim by more than 4,000. He recently was banned for life from the pharmaceutical industry.

cnbc.com

Federal judge bans Martin Shkreli from the pharmaceutical industry for life, orders him to pay $64.6 million fine

The so-called "Pharma Bro" was sued in early 2020 for an alleged antitrust violation over the price of the drug Daraprim.

news.yahoo.com

'Pharma Bro' Martin Shkreli is ordered to return $64M, barred from drug industry

Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a life-saving drug, a federal judge ruled.

npr.org
Ad

Pharma Bro Martin Shkreli banned for life from drug industry, ordered to pay $64.6 million

"Pharma Bro" Martin Shkreli was banned for life from the pharmaceutical industry and ordered to pay $64.6 million in profits from the drug Daraprim.

cnbc.com

Shkreli ordered to return $64M, is barred from drug industry

A federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.

'Pharma Bro' firm reaches $40M settlement in gouging case

A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug.

U.S. sells one-of-a-kind Wu-Tang Clan album seized from Martin Shkreli

Proceeds for the sale will go towards Shkreli's court-ordered fines and payments.

cbsnews.com

Mystery buyer of Wu-Tang Clan album forfeited by Martin Shkreli will reveal identity soon, lawyer says

A Wu-Tang Clan album once owned by felon Martin Shkreli was sold by the U.S. government to satisfy as much as a $2.3 million forfeiture balance.

cnbc.com

Wu-Tang Clan album sale pays off ‘Pharma Bro’ Martin Shkreli’s court debt

The entrepreneur known as “Pharma Bro” once boasted that he paid $2 million in 2015 at auction for “Once Upon a Time in Shaolin,” the 31-track double album the Wu-Tang Clan spent six years creating. Authorities said the sales contract for the album contained a confidentiality provision that protects information relating to the buyer and price. In a civil case in Manhattan federal court, lawyers wrote in an April document that Shkreli had already reduced his forfeiture debt by about $5 million. Shkreli’s purchase of the Wu-Tang Clan album came as group member RZA said he wanted the album — packaged in a hand-crafted silver and nickel case which includes a 174-page book wrapped in leather — to be viewed as a piece of contemporary art. Brafman described Shkreli at sentencing as a misunderstood eccentric who used unconventional means to make his defrauded investors even wealthier.

mlive.com

Wu-Tang Clan album sale pays off Martin Shkreli's court debt

An unreleased Wu-Tang Clan album forfeited by Martin Shkreli after his fraud conviction has been sold.

United States sells one-of-a-kind Wu-Tang Clan album seized from Martin Shkreli

The proceeds for the sale will go towards Shkreli's court-ordered fines and payments.

cbsnews.com

Wu-Tang Clan Album Once Owned By Martin Shkreli Sold By U.S. Government

There was only one copy of Once Upon a Time in Shaolin, and the government forced Shkreli to turn it over after his fraud conviction. Details are confidential, so don't expect to hear it anytime soon.

npr.org
Ad

U.S. sells one-of-a-kind Wu-Tang Clan album forfeited by 'Pharma Bro' Martin Shkreli

A unique Wu-Tang Clan album has been sold by the U.S. government, after Pharma Bro Martin Shkreli forfeited it as part of his 2017 federal criminal conviction.

cnbc.com

AP's Nixon wins News Leader of the Year award from NLA

The News Leaders Association has given Ron Nixon of The Associated Press its first-ever News Leader of the Year award.

"Pharma Bro" Martin Shkreli denied early prison release for second time

Matsumoto noted that Shkreli recently had a two-hour Zoom session with his lawyers, as well as several phone calls up to an hour in length. Prosecutors said that, as of January 6, there were no positive cases in Shkreli's housing unit. In her ruling, Matsumoto wrote that Shkreli is a "relatively young and healthy man" and won't be at high risk of severe complications if he were to contract the disease. Shkreli, who was ordered to forfeit $7.3 million as part of his sentence, is due to be released from prison in September 2023. In his original request for compassionate release, Shkreli asked to be let out of prison for three months to put his background "as a successful two-time biopharma entrepreneur" to work researching a coronavirus treatment "under strict supervision."

cbsnews.com

'Pharma Bro' Shkreli loses 2nd bid for early prison release

FILE - In this Aug. 3, 2017, file photo, Martin Shkreli arrives at federal court in New York. Matsumoto noted that Shkreli recently had a two-hour Zoom session with his lawyers, as well as several phone calls up to an hour in length. Prosecutors said that, as of Jan. 6, there were no positive cases in Shkreli’s housing unit. Shkreli, who was ordered to forfeit $7.3 million as part of his sentence, is due to be released from prison in September 2023. He is also known for attacking critics on social media and offering a bounty to anyone who could give him one of Hillary Clinton’s hairs.

Why that ad for butt-flap pajamas is following you all over the internet

But for me, it's just the latest crappy e-commerce ad, which are all over the internet these days. But none of these have captured the eye of so many quite like the butt-flap pajamas. There are several ways this particular ad simultaneously could have found its way onto the screens of many. As for the actual design of the ad, Vidakovic says it's likely very intentional as well. "It means that brand, whoever is paying for these ads, they're probably paying a not insignificant amount," he said.

cnbc.com

'Delusional' Martin Shkreli denied prison release by judge

NEW YORK A judge rejected the request of convicted pharmaceutical executive Martin Shkreli to be let out of prison to research a coronavirus treatment, noting that probation officials viewed that claim as the type of delusional self-aggrandizing behavior that led to his conviction. U.S. District Judge Kiyo Matsumoto said in a nine-page ruling Saturday that the man known as the Pharma Bro" failed to demonstrate extraordinary and compelling factors that would require his release under home confinement rules designed to move vulnerable inmates out of institutions during the pandemic. Disappointed but not unexpected, Shkrelis lawyer, Benjamin Brafman, said. A judge ordered Shkreli to forfeit $7.3 million. He is also known for attacking critics on social media and offering a bounty to anyone who could give him one of Hillary Clintons hairs.

Prosecutors oppose Martin Shkreli's coronavirus early prison release bid, call him 'delusional,' greedy

Federal prosecutors on Wednesday called notorious pharmaceutical industry fraudster Martin Shkreli "delusional" and greedy as they opposed his bid to win early release from prison to both avoid catching the coronavirus and to work on a potential cure for it. Shkreli's lawyer, Benjamin Brafman, when asked for comment about the prosecutors' new filing, wrote in an email, 'Was hoping for a more compassionate response." Their filing said Shkreli's own request last week belies the need to release him so that he can continue his research into a coronavirus treatment. "There is no evidence that Shkreli has changed in this, or any other, respect," prosecutors wrote. "Shkreli continues to believe that the rules do not apply to him," prosecutors wrote.

cnbc.com

Federal Trade Commission, New York Attorney General seek lifetime ban for 'Pharma bro' Martin Shkreli for 'illegally monopolizing' drug

Ex-pharmaceutical executive Martin Shkreli arrives at the U.S. District Court for the Eastern District of New York in June, 2017. The Federal Trade Commission and New York's attorney general on Monday sued incarcerated "pharma bro" Martin Shkreli and his firm Vyera Pharmaceuticals for allegedly "illegally monopolizing" the anti-parasite medication Daraprim costing patients and other purchasers to pay tens of millions of dollars more each year than they otherwise would. "Daraprim is a lifesaving drug for vulnerable patients," said Gail Levine, Deputy Director of the Bureau of Competition at the Federal Trade Commission. "Vyera kept the price of Daraprim astronomically high by illegally boxing out the competition." And the suit the suit seeks to enjoin Vyera's conduct, and obtain monetary relief from the alleged victims of the company's conduct.

cnbc.com

"Pharma Bro" does video chat with public following congressional hearing

In a video live chat Thursday, Martin Shkreli took questions from the general public following a congressional hearing in Washington, D.C. where he stonewalled Congress. And Congress wasn't the only one Shkreli stonewalled. When CBS News' Valdimir Duthiers joined the online video chat, Shkreli immediately shut him down. CBSN has more.

cbsnews.com
Ad

Feds: Notorious pharma CEO scammed investors out of millions

Pharmaceutical CEO Martin Shkreli who was accused of price gouging is out on bail after his arrest Thursday on unrelated securities fraud charges. Federal prosecutors allege Shkreli lied and stole to keep his other companies afloat. He was already called a symbol of corporate greed after his drug company raised the price of a medicine by more than 5,000 percent. Anthony Mason reports.

cbsnews.com

What's in the news today? #CBSN10 Trending Stories

Price-gouging pharma CEO Martin Shkreli arrested on securities fraud charges, San Bernardino shooter's friend charged with terrorism-related counts, and more of the stories you're clicking on.

cbsnews.com

Notorious pharmaceutical CEO Martin Shkreli arrested on fraud charges

Martin Shkreli, the notorious pharmaceutical CEO who raised the price of a life-saving drug was arrested on charges of securities fraud. St. John's University School of Law Professor Michael Perino discussed the charges with CBSN's Contessa Brewer.

cbsnews.com

12/17: Feds arrest pharma CEO on fraud charges; Star Wars superfans in heaven over new movie

Martin Shkreli, the pharmaceutical company CEO who caused a public uproar after drastically raising the price of a life-saving prescription drug, was arrested on Thursday; Some superfans bring their devotion to Star Wars into their every-day lives.

cbsnews.com

Details on drug company CEO's arrest

Martin Shkreli, who ignited a firestorm when he hiked the price of a life-saving drug from $13.50 up to $750, was arrested Thursday on an unrelated matter. CBS News' DeMarco Morgan and Attorney Matthew Kaiser explain the federal case against him for securities fraud.

cbsnews.com

Martin Shkreli, controversial drug CEO, arrested for fraud

Controversial Turing Pharmaceuticals CEO Martin Shkreli has been arrested on charges of securities fraud. CBS News correspondent DeMarco Morgan has the latest for CBSN.

cbsnews.com

Who is Turing Pharmaceuticals' Martin Shkreli?

Turing Pharmaceuticals CEO Martin Shkreli is the focus of even more scrutiny following his arrest for securities fraud. CBS News correspondent Vinita Nair joins CBSN with details.

cbsnews.com

Turing CEO will keep high Daraprim price for individuals

There is more controversy over prescription drug prices and Turing Pharmaceuticals CEO Martin Shkreli. Shkreli caused a public uproar when he drastically raised the price of a lifesaving drug for cancer and AIDS patients. He promised to cut the cost, but that was two months ago. Now he's saying he will reduce the price for hospitals only, not individuals. Don Dahler reports.

cbsnews.com

Turing Pharmaceuticals CEO defends Daraprim price hike

When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the move is simply a smart business decision.

cbsnews.com
  • TV Listings
  • Contests and Rules
  • Email Newsletters
  • RSS Feeds
  • Closed Captioning
  • Contact Us
  • Careers at WDIV
  • Terms of Use
  • Privacy Policy
  • Public File
  • FCC Applications
  • Do Not Sell My Info
Follow Us
facebook
twitter
instagram
snapchat
rss
Get Results with Omne
Omne Results Logo

If you need help with the Public File, call (313) 222-0566.


Graham Media Group LogoGraham Digital Logo

Copyright © 2022 ClickOnDetroit.com is managed by Graham Digital and pubished by Graham Media Group, a division of Graham Holdings.